For Anyone Who Hasn't Had Enough of Kelo Yet
Why would this (or any other) blog need another post about Kelo v. City of New London. It probably doesn't, which is why this will be short.
But, for anyone who still wants more of the story behind Kelo, the soon-to-be-closed Pfizer facility, or the heated arguments they engender, the New YorK Times ran an extended piece, A Turning Point for Eminent Domain? on November 12 that contains a number of different, high-level views on the subject. (It also contains plenty of less than high-level views, as the story had generated 55 comments within just a few hours of its posting.)
And, for anyone who still wants more, New York Times reporter Patrick McGeehan wrote another November 12 article, "Pfizer to Leave City That Won Supreme Court Land-Use Case," which focuses, oddly enough, on the Pfizer part of the tale.
